IDH1 and glioblastoma: The self-amplifying dual feed-forward loops driven by ‘active’ LOC–DHX15 also explain why sustained cancer cell–GAM synergism is at the core of oncogenesis, therapy resistance and the poorer prognosis of IDH-wild-type glioblastoma.